Levocetirizine Eg

Levocetirizine, the active ingredient in Levocetirizine Eg, is a second‑generation antihistamine presented as an oral tablet for oral use. It is indicated for the relief of symptoms associated with allergic rhinitis and chronic idiopathic urticaria in appropriate patient populations.

GNH USA supplies Levocetirizine Eg as a licensed, GDP‑compliant international pharmaceutical product, adhering to EU quality standards. The company provides reliable sourcing to hospitals, pharmacies and clinics worldwide, supporting global procurement with regulatory documentation and consistent batch release and timely delivery.

Levocetirizine is a second‑generation antihistamine that acts on histamine‑mediated allergic conditions.

Allergic rhinitis: reduces sneezing, nasal itching, rhinorrhea and congestion. Seasonal allergic rhinitis: provides symptom control during pollen seasons. Chronic idiopathic urticaria: alleviates wheals and itching associated with chronic hives.

Levocetirizine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Drowsiness or mild sedation. - Headache. - Dry mouth. - Fatigue. - Nausea. - Altered taste perception.

Serious or Rare Side Effects: - Angioedema or severe swelling of face, lips or throat. - Anaphylactic reactions. - Hepatic enzyme elevation. - Neutropenia or other blood dyscrasias. - Severe skin rash such as Stevens‑Johnson syndrome. - Cardiovascular arrhythmias (very rare).

When prescribing Levocetirizine, clinicians should consider several safety aspects.

Assess renal function: dose adjustment may be required in severe renal impairment. Monitor for sedation: advise patients to avoid operating machinery if drowsiness occurs. Avoid use in known hypersensitivity: discontinue immediately if allergic reaction develops. Use with caution in pregnancy: limited data, prescribe only if benefit outweighs risk. Review concomitant CNS depressants: potential additive sedation. Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Levocetirizine may interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) may increase levocetirizine plasma levels. - Monoamine oxidase inhibitors (MAOIs) can potentiate antihistaminic effects.

Moderate Interactions (Monitor Closely): - Alcohol or other CNS depressants: may enhance sedation. - Other antihistamines or anticholinergic agents: risk of additive anticholinergic burden. - Certain antibiotics (e.g., erythromycin): may modestly raise drug concentrations.